You are here: Industry Insights > indication

News List

BeiGene submits application for the fifth indication for Tislelizumab Injection PharmaSources/Xiaoyaowan
June 30, 2020
On June 29, the official website of CDE showed that the PD-1 antibody of BeiGene submitted a new indication application for Tislelizumab injection and was accepted.
A New Indication of Secukinumab to be Approved in China! PharmaSources/Caicai
April 26, 2020
The marketing application (acceptance No. JXSS1900025) of a new indication of Novartis’ secukinumab in China has recently changed to “Under approval” and is expected to be approved soon. First approved by the NMPA for marketing in Mar. 2019, this will be
Medtronic Evolut TAVR System receives expanded indication biospectrumasia
August 20, 2019
Expanded TAVR Indication to Younger, More Active Patients Signals Groundbreaking Shift in the Future Treatment of Heart Valve Disease
Dupixent® Approved for Severe Asthma by European Commission americanpharmaceuticalreview
May 08, 2019
Regeneron Pharmaceuticals and Sanofi announced that the European Commission (EC) approved a new indication for Dupixent® (dupilumab) in asthma.
Trelegy Ellipta Gains Expanded COPD Indication in Europe americanpharmaceuticalreview
November 10, 2018
“We are pleased that the European Commission has approved the expanded use of Trelegy Ellipta as this will enable even more COPD patients to benefit from this important medicine,” Dr. Hal Barron, Chief Scientific Officer and President, R&D, GSK, said.
European Commission Approves Expanded Indication Blincyto americanpharmaceuticalreview
August 30, 2018
Amgen announced the European Commission (EC) has approved an expanded indication for Blincyto (blinatumomab) as monotherapy for the treatment of pediatric patients aged one year or older with Philadelphia chromosome-negative CD19 positive B-cell precursor